PRECISION IN EVERY SEQUENCE.   For research and laboratory use only.
HELIX SYNTHESIS / RESEARCH GUIDE

Peptide reference guide.

The science behind the collection. Explore compound identities, research areas, and evidence limitations across 39 Helix materials.

For laboratory research only. Not medical advice or a therapeutic claim.

Visit the shop
24 of 24 compound guides

Research findings depend on molecular identity, formulation, and study design. A vial’s listed amount is a material specification—not an administration recommendation. Verified batch reports are not currently published.

Beauty / Wellness

3 guides
COMPOUND REFERENCE

GHK-Cu

Copper-binding tripeptide

Helix Synthesis GHK-Cu 50mg vial

GHK-Cu is a copper complex of the glycyl-L-histidyl-L-lysine peptide. It is investigated in extracellular-matrix remodeling, wound models, and skin biology.

Research focus

  • Collagen and extracellular-matrix signaling
  • Oxidative stress and tissue-remodeling models

Evidence & limitations

  • Findings depend on formulation and experimental model.
  • Topical studies do not establish the safety or effects of other routes.
AVAILABLE MATERIALS
COMPOUND REFERENCE

Glow

Owner-listed research blend

Helix Synthesis Glow 70mg vial

Glow is listed as a 70mg blend in the Helix collection. The product name alone does not establish its component identities or their individual amounts.

Research focus

  • Confirm component identities and proportions before selecting a study.
  • Use component-specific literature and appropriate controls.

Evidence & limitations

  • Verified blend composition is not currently published.
  • Results from individual peptides cannot be assumed to apply to a blend.
AVAILABLE MATERIALS
COMPOUND REFERENCE

Glutathione

Redox-active tripeptide

Helix Synthesis Glutathione 1500mg vial

Glutathione is composed of glutamate, cysteine, and glycine. It participates in cellular redox balance and enzyme-mediated antioxidant processes.

Research focus

  • Glutathione-dependent antioxidant pathways
  • Cellular oxidative-stress and detoxification models

Evidence & limitations

  • Reduced and oxidized forms have different experimental roles.
  • Stability and preparation can influence assay results.
AVAILABLE MATERIALS

Fat Loss / Metabolic

6 guides
COMPOUND REFERENCE

5-Amino-1MQ

Small-molecule NNMT inhibitor

Helix Synthesis 5-Amino-1MQ 10mg vial

5-Amino-1MQ is studied as an inhibitor of nicotinamide N-methyltransferase, an enzyme involved in nicotinamide metabolism. It is a small molecule, not a peptide.

Research focus

  • NNMT activity and nicotinamide metabolism
  • Metabolic and adipose-tissue models

Evidence & limitations

  • Much of the evidence is preclinical.
  • Animal findings do not establish human efficacy or long-term safety.
COMPOUND REFERENCE

Klow

Owner-listed research blend

Helix Synthesis Klow 80mg vial

Klow is listed as an 80mg blend. Its exact formulation needs material-specific documentation before findings from any proposed constituent can be applied.

Research focus

  • Verify constituent identities and individual quantities.
  • Compare blend outcomes with component-only controls.

Evidence & limitations

  • Verified component ratios are not currently published.
  • A total vial amount does not describe each ingredient’s concentration.
AVAILABLE MATERIALS
COMPOUND REFERENCE

Lemon Bottle

Branded solution · 10ml format

Helix Synthesis Lemon Bottle 10ml vial

Lemon Bottle is supplied in a volume-based format. A brand name and vial volume are insufficient to determine the chemical composition or concentration of a solution.

Research focus

  • Obtain an ingredient list and concentration specifications.
  • Review formulation-specific analytical and safety documentation.

Evidence & limitations

  • Composition is not verified on this site.
  • Brand marketing should not be treated as evidence of safety or efficacy.
AVAILABLE MATERIALS
COMPOUND REFERENCE

GLP-RT

Catalog code · identity confirmation required

Helix Synthesis GLP-RT10 10mg vial

The Helix collection uses GLP-RT codes for several vial amounts. Confirm the molecular identity with the supplier before matching these products to literature on incretin receptor agonists.

Research focus

  • Confirm sequence or chemical identity and receptor selectivity.
  • Evaluate metabolic endpoints only against identity-matched literature.

Evidence & limitations

  • A catalog code is not a verified chemical identity.
  • Do not infer approval, clinical equivalence, or safety from a similar name.
COMPOUND REFERENCE

SLU-PP-332

Experimental estrogen-related receptor agonist

Helix Synthesis SLU-PP-332 5mg vial

SLU-PP-332 is an experimental small molecule investigated for activation of estrogen-related receptors and changes in oxidative metabolism in preclinical models.

Research focus

  • Estrogen-related receptor signaling
  • Oxidative metabolism and skeletal-muscle models

Evidence & limitations

  • Published findings are predominantly preclinical.
  • Human safety and efficacy are not established.
AVAILABLE MATERIALS
COMPOUND REFERENCE

GLP-TR

Catalog code · identity confirmation required

Helix Synthesis GLP-TR10 10mg vial

GLP-TR materials are grouped by their Helix catalog codes. The codes alone do not verify a specific molecule or permit direct comparison with approved or investigational incretin products.

Research focus

  • Request molecular identity and material specifications.
  • Use identity-matched research and validated assay controls.

Evidence & limitations

  • No identity verification is published on this site.
  • Vial amount is not a dosing recommendation or proof of clinical equivalence.

Focus / Mood / Sleep

3 guides
COMPOUND REFERENCE

Semax

Synthetic ACTH-fragment analog

Helix Synthesis Semax 10mg vial

Semax is a synthetic peptide related to an adrenocorticotropic hormone fragment. It has been studied in neurotrophic signaling and neurological experimental models.

Research focus

  • Neurotrophic signaling, including BDNF-related pathways
  • Neuronal stress and ischemia models

Evidence & limitations

  • Evidence quality and study populations vary.
  • Experimental findings do not establish a general cognitive benefit.
AVAILABLE MATERIALS
COMPOUND REFERENCE

Selank

Synthetic tuftsin analog

Helix Synthesis Selank 10mg vial

Selank is a synthetic heptapeptide derived from tuftsin. Research has explored neurochemical signaling and behavioral endpoints alongside immune-related pathways.

Research focus

  • Neurotransmitter and stress-response models
  • Immune signaling and gene-expression endpoints

Evidence & limitations

  • Large, independently replicated clinical evidence is limited.
  • Behavioral findings are model- and protocol-dependent.
AVAILABLE MATERIALS
COMPOUND REFERENCE

DSIP

Delta sleep-inducing peptide

Helix Synthesis DSIP 10mg vial

DSIP is a nonapeptide investigated in sleep-related and stress-response research. Its historical name should not be interpreted as a proven effect on human sleep.

Research focus

  • Sleep physiology and neuroendocrine signaling
  • Stress-response endpoints in experimental models

Evidence & limitations

  • Reported sleep effects are inconsistent across studies.
  • Mechanisms and clinical relevance remain uncertain.
AVAILABLE MATERIALS

Hormone / GH Support

3 guides
COMPOUND REFERENCE

CJC1295 + Ipamorelin

Growth-hormone signaling research blend

Helix Synthesis CJC1295 + Ipamorelin 10mg vial

CJC-1295 is associated with GHRH-receptor signaling, while ipamorelin is a ghrelin-receptor agonist. The Helix item is a combined 10mg material; its component ratio and CJC formulation require confirmation.

Research focus

  • GHRH and ghrelin-receptor pathways
  • Separate constituent responses from combined-material effects.

Evidence & limitations

  • DAC and non-DAC formulations must not be treated as equivalent.
  • Component ratios and blend-specific evidence are not verified here.
AVAILABLE MATERIALS
COMPOUND REFERENCE

Tesamorelin

Growth hormone-releasing hormone analog

Helix Synthesis Tesamorelin 10mg vial

Tesamorelin is a GHRH analog studied in growth-hormone signaling and metabolic endpoints. Evidence for regulated pharmaceutical formulations does not establish equivalence of a research vial.

Research focus

  • Pituitary GHRH-receptor and GH/IGF-1 signaling
  • Metabolic endpoints in defined study populations

Evidence & limitations

  • Endocrine and glucose-related effects require careful interpretation.
  • Research materials are not interchangeable with approved medicines.
COMPOUND REFERENCE

PT-141

Bremelanotide · melanocortin receptor agonist

Helix Synthesis PT-141 10mg vial

PT-141 is a cyclic peptide associated with melanocortin receptor signaling. Published bremelanotide studies evaluate specific pharmaceutical formulations and populations.

Research focus

  • Melanocortin receptor activity
  • Central nervous system signaling endpoints

Evidence & limitations

  • Clinical literature reports nausea and transient blood-pressure changes.
  • Approval of a medicine does not establish this research material’s equivalence.
AVAILABLE MATERIALS

Longevity / Specialty

3 guides
COMPOUND REFERENCE

MOTS-c

Mitochondrial-derived peptide

Helix Synthesis MOTS-c 10mg vial

MOTS-c is a 16-amino-acid peptide associated with mitochondrial biology. It is investigated in metabolic regulation and cellular stress-response models.

Research focus

  • AMPK-associated metabolic signaling
  • Mitochondrial stress and metabolic homeostasis

Evidence & limitations

  • Much of the intervention evidence comes from experimental models.
  • Associations in humans do not prove benefit from administration.
AVAILABLE MATERIALS
COMPOUND REFERENCE

NAD+

Nicotinamide adenine dinucleotide

Helix Synthesis NAD+ 500mg vial

NAD+ is a coenzyme involved in redox reactions and a substrate for enzymes such as sirtuins and PARPs. Research distinguishes NAD+ itself from its precursors.

Research focus

  • Cellular redox and energy metabolism
  • PARP, sirtuin, and NAD-consuming enzyme pathways

Evidence & limitations

  • Precursor studies cannot automatically be applied to NAD+ materials.
  • Biochemical function is not proof of an anti-aging treatment effect.
AVAILABLE MATERIALS
COMPOUND REFERENCE

SS31

Elamipretide · mitochondria-targeted peptide

Helix Synthesis SS31 10mg vial

SS31 is a tetrapeptide investigated in relation to mitochondrial membranes and cardiolipin. Studies explore mitochondrial bioenergetics in specific experimental and clinical settings.

Research focus

  • Cardiolipin-associated mitochondrial processes
  • Bioenergetics and oxidative-stress endpoints

Evidence & limitations

  • Outcomes vary by disease model and study population.
  • Findings from pharmaceutical formulations do not verify this material.
AVAILABLE MATERIALS

Recovery / Healing

6 guides
COMPOUND REFERENCE

BPC-157

Experimental pentadecapeptide

Helix Synthesis BPC-157 10mg vial

BPC-157 is investigated primarily in preclinical gastrointestinal and tissue-injury models. Published animal findings are not established human therapeutic effects.

Research focus

  • Tissue-injury and repair models
  • Gastrointestinal and vascular signaling endpoints

Evidence & limitations

  • Robust human efficacy and safety evidence is limited.
  • Preclinical repair findings should not be presented as proven healing benefits.
AVAILABLE MATERIALS
COMPOUND REFERENCE

KPV

Lysine–proline–valine tripeptide

Helix Synthesis KPV 10mg vial

KPV is the C-terminal tripeptide associated with alpha-melanocyte-stimulating hormone. It has been investigated in inflammatory signaling and barrier-function models.

Research focus

  • Inflammatory signaling pathways
  • Epithelial and intestinal experimental models

Evidence & limitations

  • Evidence is largely preclinical.
  • Formulation and exposure conditions affect interpretation.
AVAILABLE MATERIALS
COMPOUND REFERENCE

Wolverine Stack

Owner-listed research blend

Helix Synthesis Wolverine Stack 20mg vial

Wolverine Stack is listed as a 20mg blend. Confirm constituent identities and their amounts rather than inferring composition from the product name.

Research focus

  • Verify the blend’s component specifications.
  • Design constituent-only and combined-material controls.

Evidence & limitations

  • Composition and component proportions are not verified here.
  • A blend name does not establish repair effects or clinical safety.
AVAILABLE MATERIALS
COMPOUND REFERENCE

IGF-1LR3

Modified insulin-like growth factor analog

Helix Synthesis IGF-1LR3 1mg vial

IGF-1 LR3 is an engineered IGF-1 analog used in growth-factor signaling research. Its altered interaction with binding proteins distinguishes it from native IGF-1.

Research focus

  • IGF-receptor and downstream growth signaling
  • Cell proliferation and metabolic assay endpoints

Evidence & limitations

  • Growth signaling requires careful model and safety selection.
  • Glucose-related and proliferative effects prevent assuming general safety.
AVAILABLE MATERIALS
COMPOUND REFERENCE

ARA-290

Cibinetide · erythropoietin-derived peptide

Helix Synthesis ARA-290 10mg vial

ARA-290 is an erythropoietin-derived peptide investigated for tissue-protective signaling without the full erythropoietic activity of erythropoietin.

Research focus

  • Tissue-protective and inflammatory signaling
  • Peripheral nerve and injury-model endpoints

Evidence & limitations

  • Clinical findings are limited to specific investigational settings.
  • Mechanistic rationale is not established therapeutic efficacy.
AVAILABLE MATERIALS
COMPOUND REFERENCE

TB500 (Thymosin B4 Acetate)

Thymosin-related research material

Helix Synthesis TB500 (Thymosin B4 Acetate) 10mg vial

Thymosin beta-4 is an actin-binding peptide investigated in cell migration and tissue-remodeling models. TB500 naming is not consistently used for the same sequence across suppliers.

Research focus

  • Confirm the supplied sequence and molecular identity.
  • Actin-associated processes and cell-migration models

Evidence & limitations

  • Full-length thymosin beta-4 and fragments are not interchangeable.
  • Evidence must match the specific material identity.
CONTINUE YOUR RESEARCH

Context matters.

Review analytical methods, material handling, and research-use information.

Research resources Frequently asked questions

A stronger foundation for discovery.

Explore the materials behind your next research question.

Explore the guide